Internal Reference Number: FOI_6585
Date Request Received: 11/05/2022 00:00:00
Date Request Replied To: 13/05/2022 00:00:00
This response was sent via: By Email
Request Summary: Biologic medicines
Request Category: Companies
| Question Number 1: I have a freedom of information request regarding the use of Biologic medicines. Could you please answer the following two questions: How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs: 鈥� Adalimumab - Humira 鈥� Adalimumab Biosimilar 鈥� Apremilast 鈥� Bimekizumab 鈥� Brodalumab 鈥� Certolizumab 鈥� Dimethyl fumarate 鈥� Etanercept - Enbrel 鈥� Etanercept Biosimilar 鈥� Guselkumab 鈥� Infliximab - Remicade 鈥� Infliximab Biosimilar 鈥� Ixekizumab 鈥� Risankizumab 鈥� Secukinumab 鈥� Tildrakizumab 鈥� Ustekinumab | |
| Answer To Question 1: adalimumab (Humira) 8 adalimumab (biosimilar) 24 apremilast <5 bimekizumab 0 brodalumab 10 certolizumab <5 dimethyl fumarate 0 etanercept (Enbrel) 0 etanercept (biosimilar) 0 guselkumab 11 infliximab (Remicade) 0 infliximab (biosimilar) 0 ixekizumab <5 risankizumab 0 secukinumab 5 tildrakizumab <5 ustekinumab 18 | |
| Question Number 2: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: 鈥� Adalimumab - Humira 鈥� Adalimumab Biosimilar 鈥� Filgotinib 鈥� Golimumab 鈥� Infliximab - Remicade 鈥� Infliximab Biosimilar 鈥� Ozanimod 鈥� Tofacitinib 鈥� Ustekinumab 鈥� Vedolizumab | |
| Answer To Question 2: adalimumab (Humira) 6 adalimumab (biosimilar) 60 filgotinib 0 golimumab <5 infliximab (Remicade) 9 infliximab biosimilar 118 ozanimod 0 tofacitinib <5 ustekinumab 37 vedolizumab 35 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
